VP Medical Affairs, Transcatheter Mitral & Tricuspid Therapies (TMTT)
Edwards Lifesciences
Irvine, California, United States
Ted Feldman, M.D., joined Edwards Lifesciences in 2019 as vice president of global medical affairs for Transcatheter Mitral and Tricuspid Therapies (TMTT), where he leads professional education, scientific communication and clinical trial design across the portfolio. Highly regarded as a leader in interventional cardiology, he has performed thousands of catheter procedures. He has authored more than 700 manuscripts, chapters, abstracts, and editorials, edited or co-edited several books, and served on numerous journal editorial boards. He is past president and Master Fellow of the Society of Cardiovascular Angiography & Interventions (SCAI) and also chaired the Annual Scientific Sessions and Fellows Course. He has served as the global principal investigator for several ground breaking clinical trials involving transcatheter mitral and tricuspid therapies.